LYEL - Lyell Immunopharma Inc
21.49
-1.130 -5.258%
Share volume: 63,263
Last Updated: 04-28-2026
Pharmaceutical Products/Pharmaceutical Preparations:
-0.12%
PREVIOUS CLOSE
CHG
CHG%
$22.62
-1.13
-0.05%
Summary score
42%
Profitability
35%
Dept financing
23%
Liquidity
58%
Performance
50%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 31-Dec-2021 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-6.76%
Return on assets
-12.09%
Return on sales
-713384.19%
Return on invested capital
-22.92%
Total debt ratio
15.91%
Debt ratio change over timeo
-1.94%
Current Ratio
13.73%
Quick Ratio
16.21%
Cash Position Ratio
9.9%
Short-term ratios 31-Dec-2024 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-21.84%
Return on sales
-1065093.97%
Return on invested capital
0%
Total debt ratio
22.68%
Debt ratio change over timeo
0%
Current Ratio
7.69%
Quick Ratio
0%
Cash Position Ratio
2.67%
Last quarter ratios 31-Dec-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-42.17%
Return on sales
-2127400%
Return on invested capital
0%
Total debt ratio
27.01%
Debt ratio change over time
0%
Current Ratio
5.28%
Quick Ratio
0%
Cash Position Ratio
1.22%
Performance ratios (change over 4 years) 31-Dec-2021 - 31-Dec-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-38.14%
Return on assets
-49.81%
Return on sales
3776987.02%
Return on invested capital
114.17%
Total debt ratio
-194.03%
Debt ratio change over time
-1.94%
Current Ratio
-134.81%
Quick Ratio
-146.76%
Cash Position Ratio
-127.71%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | LYEL | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -6.76% | 12.23% | 10.41% | 0% |
| Return on assets | -12.09% | 4.74% | 3.19% | 1.73% |
| Return on sales | -713384.19% | 30.88% | 25.28% | 24.06% |
| Return on invested capital | -22.92% | 8.04% | 10.95% | 0% |
| Profitability | 0% | 93% | 84% | 29% |
| Total debt ratio | 15.91% | 80.37% | 59.38% | 94.09% |
| Debt ratio change over time | -1.94% | -20.57% | -85.61% | 17.33% |
| Dept financing | 4% | 21% | 16% | 50% |
| Current Ratio | 7.69% | 1.44% | 1.09% | 0.72% |
| Quick Ratio | 0% | 1.12% | 0.84% | 0.6% |
| Cash Position Ratio | 2.67% | 0.16% | 0.44% | 0.14% |
| Liquididy | 75% | 4% | 5% | 3% |
| Short-term ratios | LYEL | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -21.84% | 6.06% | 4.18% | 1.7% |
| Return on sales | -1065093.97% | 39.61% | 26.91% | 24.78% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 50% | 34% | 23% |
| Total debt ratio | 22.68% | 80% | 59.26% | 100.88% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 31% | 20% | 15% | 25% |
| Current Ratio | 7.69% | 1.44% | 1.09% | 0.72% |
| Quick Ratio | 0% | 1.12% | 0.84% | 0.6% |
| Cash Position Ratio | 2.67% | 0.16% | 0.44% | 0.14% |
| Liquididy | 50% | 31% | 26% | 17% |